dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline Prescribing pearls: A guide to inhibitors (gliptins) 𝐋𝐚𝐭𝐞𝐬𝐭 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐃𝐏𝐏-𝟒 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬
Description
This innovative oral GLP-1 is a small molecule medication that, unlike the Wegovy pill, doesnt require that you take it on an empty stomach.
William Meller, MD, examines the GLP-1 drug phenomenon
Understand causes, benefits, and practical insights to support better health and informed decisions.
A comprehensive phase 3 program is ongoing to evaluate efficacy, safety, and cardiovascular/renal outcomes in people with obesity and/or T2D
Moreover, the addition of finerenone to this combination therapy could potentially provide stronger cardiorenal protective benefits
Glucagon-like peptide-1 (GLP-1) is one of the incretins that regulate glucose metabolism
